Vitamin E and thyroid disease: A potential link that kindles hope

BioFactors

Volumn 19, Issue 3-4, 2003, Pages 131-135

  Duntas, Leonidas H ^a,c   Orgiazzi, Jacques ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITÉ DE LYON   (France)

^c Evgenidion Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTITHYROID AGENT; BETA CAROTENE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; ORAL CONTRACEPTIVE AGENT; SELENIUM; THIAMAZOLE; THYMIDINE DERIVATIVE; UBIQUINONE;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; CONFERENCE PAPER; ENZYME BLOOD LEVEL; GRAVES DISEASE; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; THYROID CANCER; THYROID DISEASE;

EID: 0842264909     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520190305     Document Type: Conference Paper

References (34)

1. H.M. Evans and K.S. Bishop, Fetal resorption, Science 55 (1922), 650.
2. G. Rimbach, A.M. Minihane, J. Majewicz, A. Fischer, J. Pallauf, I. Virgli and P.D. Weinberg, Regulation of cell signalling by vitamin E, Proc. Nutr. Soc. 61 (2002), 415-425.
3. D.A. Butterfield, A. Castegna, J. Drake, G. Scapagnini and V. Calabrese, Vitamin E and neurodegenerative disorders associated with oxidative stress, Nutr. Neurosc. 5 (2002), 229-239.
4. D.E. Kaempf-Rotzoll, M.G. Traber and H. Arai, Vitamin E and transfer proteins, Curr Opin Lipidol 14 (2003), 249-254.
5. B. Halliwell and J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Meth Enzymol 186 (1990), 1-85.
6. A. Azzi, E. Aratri, D. Boscoboinik, S. Clement, N.K. Ozer, R. Ricciarelli and S. Spycher, Molecular basis of α-tocopherol control of smooth muscle cell proliferation, Biofactors 7 (1998), 3-14.
7. D. Boscoboinik, A. Szewczyk, C. Hensey and A. Azzi, Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C, J Biol Chem 266 (1991), 6188-6194.
8. A. Azzi, D. Boscoboinik, S. Clement, N. Ozer, R. Ricciarelli and A. Stocker, Diab Res Clin Pract 45 (1999), 191-198.
9. E.A. Meagher, Treatment of atherosclerosis in the new millennium: is there role for vitamin E? Prev Cardiol 6 (2003), 85-90.
10. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu and E.J. Topol, Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials, Lancet 14 (2003), 2017-2023.
11. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N. Engl. J. Med. 336 (1997), 1216-1222.
12. A. Bendich and L.J. Machlin, Safety of oral intake of vitamin E, Am J Clin Nutr 48 (1988), 612-619.
13. T.W. Anderson and D.B.W. Reid, Adouble blind trial of vitamin E in angina pectoris, Am J Clin Nutr 27 (1974), 1174-1178.
14. J.R. Arthur and G.J. Beckett, Thyroid function, Br Med Bull 55 (1999), 658-668.
15. J.F. Mutaku, M.C. Many, I. Colin, J.F. Denef and M.F. Hove, Antigoitrogenic effect of combined supplementation with dl-α-tocopherol, ascorbic acid and β-carotene and of dl-α-tocopherol alone in the rat, J. Endocrinol 156 (1998), 551-561.
16. L. Flohe, W.A. Guenzler and H.H. Schock, Glutathione peroxidase: a selenoenzyme, FEBS Lett 32 (1973), 132-134.
17. D. Behme, A. Kyriakopoulos, H. Meinhold and J. Koehrle, Identification of type I iodothyronine 5′-deiodinase as a selenoenzyme, Biochem Biophys Res Comm 173 (1990), 1143-1149.
18. B. Contempre, O. Le-Moine, J.E. Dumont, J.F. Denef and M.C. Many, Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β(TGF-β), Mol Cell Endocrinol 124 (1996), 7-15.
19. W.C. Fischer and P.D. Whanger, Effects of selenium deficiency on vitamin E metabolism in rats, J Nutr Sci Vitaminol 23 (1977), 273-280.
20. M.J. Fryer, Vitamin E status and neurodegenerative disease, Nutr Neurosci 1 (1998), 327-351.
21. A.C. Tsai, J.J. Kelley, B. Peng and N. Cook, Study on the effect of megavitamin E supplementation in man, Am J Clin Nutr 31 (1978), 831-837.
22. B. D'Avanzo, E. Ron, C. La Vecchia, S. Francaschi, E. Negri and R. Zleglar, Selected micronutrient intake and thyroid carcinoma risk, Cancer 79 (1997), 2186-2192.
23. T. Mano, K. Iwase, R. Hayashi, N.Hayakawa, K. Uchimura, M. Makino, M. Nagata, Y. Sawai, N. Oda, M. Hamada, T. Aono, A. Nakai, A. Nagasaka and M. Itoh, Vitamin E and coenzyme Q concentrations in the thyroid tissues of patients with various thyroid disorders, Am J Med Sci 315 (1998), 230-232.
24. J.F. Mutaku, J.F. Poma, M.C. Many, J.F. Denef and M.F. van Den Hove, Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution, J. Endocrinol 172 (2002), 375-386.
25. U. Resch, G. Helsel, F. Tatzber and H. Sitzinger, Antioxidant status in thyroid dysfunction, Clin Chem Lab Med 40 (2002), 1132-1134.
26. N.K. Ozer, D. Boscoboinik and A. Azzi, New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis, Biochem Mol Biol Int. 35 (1995), 117-124.
27. J.M. Upston, L. Kritharides and R. Stocker, The role of vitamin E in atherosclerosis, Prog. Lipid Res. 42 (2003), 405-422.
28. S. Benvega and J. Robbins, Altered thyroid hormone binding to plasma lipoproteins in hypothyroidism, Thyroid 6 (1996), 595-600.
29. P.D. Reaven, D.A. Herold, J. Barnett and S. Edelma, Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM, Diabetes Care 18 (1995), 807-816.
30. P. Valeix, M. Zarebska, M. Bensimon, C. Cousty, S. Bertrais, P. Galan and S. Hercberg, Ultrasonic assessment of thyroid nodules, and iodine status On French adults participating in the SU.VI.MAX study, Ann. Endocrinol. (Paris) 62 (2001), 499-506.
31. G. Bianchi, E. Solaroli, V. Zaccheroni, G. Grossi, A.M. Bargossi, N. Melchio and G. Marchesini, Oxidative stress and antioxidant metabolites in patients with hyperthyroidism: effect of treatment, Horm. Metab. Res. 31 (1999), 620-624.
32. K. Komosinska-Vassev, K. Olczyk, E.J. Kucharz, C. Marcisz, K. Winsz-Szczotka and A. Kotulska, Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy, Clin. Chim. Acta 300 (2000), 107-117.
33. L.N. Guerra, S. Moiguer, M. Karner, M.C. Molina, C.M. Sreider and J.A. Burdman, Antioxidants in the treatment of Graves disease, IUBMB Life 51 (2001), 105-109.
34. R. Brigelius-Flohé, F.J. Kelly, J.T. Salonen, J. Neuzil, J.M. Zingg and A. Azzi, The European perspective on Vitamin: Current knowledge and future research, Am. J. Clin. Nutr. 76 (2002), 703-716.